Skip to main content
logo
Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
4.450
+0.020 (0.45%)
Sep 8, 2026, 11:50 AM EDT - Market open

Minerva Neurosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2121741643834
Market Cap Growth
1164.74%1019.70%-63.88%406.53%-75.19%-65.73%
Enterprise Value
19722249764033
Last Close Price
4.434.022.226.151.596.41

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--10.80---
PB Ratio
--1.28-0.60-1.51-0.424.29

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.30-0.44-2.33-2.88-3.688.32
Net Debt / Equity Ratio
0.080.16-1.50-1.44-1.880.70
Net Debt / EBITDA Ratio
0.541.48-1.77-1.78--0.18
Net Debt / FCF Ratio
0.581.65-1.98-2.78-1.53-0.23
Quick Ratio
19.0235.937.5312.2528.4621.55
Current Ratio
20.1436.287.8512.5729.1522.07
Return on Equity (ROE)
------164.60%
Return on Assets (ROA)
-28.42%-13.97%-29.04%-25.81%-23.86%-27.98%
Return on Capital Employed (ROCE)
-31.30%-15.80%-63.70%-43.20%-47.00%-40.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-186.43%-168.67%9.26%-69.77%-378.15%-145.84%
FCF Yield
-12.37%-7.77%-125.84%-34.38%-290.45%-71.89%
Buyback Yield / Dilution
-260.56%-11.75%-16.41%-21.84%0.00%-4.41%
SEC Filings: 10-K · 10-Q